Effects of ADIPOQ polymorphisms on individual susceptibility to coronary artery disease: a meta-analysis

References

• Moran AE, Forouzanfar MH, Roth G, et al. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation. 2014;129:1493–1501.
   PubMed Web of Science ®Google Scholar
• Global burden of disease study 2013 collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:743–800.
   PubMed Web of Science ®Google Scholar
• Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction. Clin Res Cardiol. 2007;96:1–7.
   PubMed Web of Science ®Google Scholar
• Evans A, Van Baal GC, McCarron P, et al. The genetics of coronary heart disease: the contribution of twin studies. Twin Res. 2003;6:432–441.
   PubMedGoogle Scholar
• Sayols-Baixeras S, Lluís-Ganella C, Lucas G, et al. Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants. Appl Clin Genet. 2014;7:15–32.
   PubMedGoogle Scholar
• Dai X, Wiernek S, Evans JP, et al. Genetics of coronary artery disease and myocardial infarction. World J Cardiol. 2016;8:1–23.
   PubMed Web of Science ®Google Scholar
• Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8:93–100.
   PubMed Web of Science ®Google Scholar
• Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol. 2017;28:347–354.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Ouchi N, Matsuzawa Y. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie. 2012;94:2137–2142.
   PubMed Web of Science ®Google Scholar
• Persson J, Lindberg K, Gustafsson TP, et al. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med. 2010;268:194–205.
   PubMed Web of Science ®Google Scholar
• Piestrzeniewicz K, Luczak K, Komorowski J, et al. Obesity and adiponectin in acute myocardial infarction. Cardiol J. 2007;14:29–36.
   PubMedGoogle Scholar
• Zhang Z, Li Y, Yang X, et al. Susceptibility of multiple polymorphisms in ADIPOQ, ADIPOR1 and ADIPOR2 genes to myocardial infarction in Han Chinese. Gene. 2018;658:10–17.
   PubMed Web of Science ®Google Scholar
• Zhong C, Zhen D, Qi Q, et al. A lack of association between adiponectin polymorphisms and coronary artery disease in a Chinese population. Genet Mol Biol. 2010;33:428–433.
   PubMed Web of Science ®Google Scholar
• Liang C, Yawei X, Qinwan W, et al. Association of AdipoQ single-nucleotide polymorphisms and smoking interaction with the risk of coronary heart disease in Chinese Han population. Clin Exp Hypertens. 2017;39:748–753.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh G, Ghaffari MA, Heibar H, et al. Association of two common single nucleotide polymorphisms (+45T/G and +276G/T) of ADIPOQ gene with coronary artery disease in type 2 diabetic patients. Iran Biomed J. 2016;20:152–160.
   PubMedGoogle Scholar
• Rizk NM, El-Menyar A, Marei I, et al. Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology. 2013;64:257–265.
   PubMed Web of Science ®Google Scholar
• Ambroziak M, Kolanowska M, Bartoszewicz Z, et al. Adiponectin gene variants and decreased adiponectin plasma levels are associated with the risk of myocardial infarction in young age. Gene. 2018;642:498–504.
   PubMed Web of Science ®Google Scholar
• Chiodini BD, Specchia C, Gori F, et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther Adv Cardiovasc Dis. 2010;4:223–230.
   PubMedGoogle Scholar
• Hegener HH, Lee IM, Cook NR, et al. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin Chem. 2006;52:2021–2027.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
   PubMed Web of Science ®Google Scholar
• Xie X, Shi X, Liu M. The roles of TLR gene polymorphisms in atherosclerosis: a systematic review and meta-analysis of 35,317 subjects. Scand J Immunol. 2017;86:50–58.
   PubMed Web of Science ®Google Scholar
• Sun H, Li Q, Jin Y, et al. Associations of tumor necrosis factor-α polymorphisms with the risk of asthma: a meta-analysis. Exp Mol Pathol. 2018;105:411–416.
   PubMed Web of Science ®Google Scholar
• Dong J, Ping Y, Wang Y, et al. The roles of endothelial nitric oxide synthase gene polymorphisms in diabetes mellitus and its associated vascular complications: a systematic review and meta-analysis. Endocrine. 2018;62:412–422.
   PubMed Web of Science ®Google Scholar
• Shi X, Xie X, Jia Y, et al. Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2016;42:844–854.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Zheng G, Hu Z. Association between SERT insertion/deletion polymorphism and the risk of irritable bowel syndrome: a meta-analysis based on 7039 subjects. Gene. 2018;679:133–137.
   PubMed Web of Science ®Google Scholar
• Xie X, Shi X, Xun X, et al. Endothelial nitric oxide synthase gene single nucleotide polymorphisms and the risk of hypertension: a meta-analysis involving 63,258 subjects. Clin Exp Hypertens. 2017;39:175–182.
   PubMed Web of Science ®Google Scholar